Pain
Conference Coverage
Pain remains after rheumatoid arthritis diagnosis
AMSTERDAM – Almost one in five people with rheumatoid arthritis still experience pain 1 year after their diagnosis.
Conference Coverage
Many veterans with comorbid pain and OUD not receiving MAT
Preliminary findings show a lot more needs to be understood about treating patients with comorbid pain and opioid use disorders.
Conference Coverage
Data suggest harm outweighs benefit of opioids for musculoskeletal pain
AMSTERDAM – There is little if any good quality evidence that opioids offer benefit in the treatment of pain related to osteoarthritis or other...
News
Obesity didn’t just happen overnight
Data seem to suggest that exercise makes Americans gain weight.
Conference Coverage
T1D neuropathy declines as glycemic control improves
ORLANDO – New research suggests the rate may have dipped, possibly due to better glycemic control.
From the Journals
Trump support high in counties with chronic opioid use
Policy to abate the opioid crisis must go beyond the medical model to incorporate socioenvironmental disadvantage factors and health behaviors.
Conference Coverage
For some SUD patients, kratom may be a self-treatment tool
SAN DIEGO – A survey finds that most users are not consuming kratom “primarily for achieving recreational ‘highs.’ ”
Conference Coverage
Do free meals to physicians affect opioid prescribing?
SAN DIEGO – Physicians who received 1 free meal made about 150 opioid claims; those who received more than 10 made more than 700 claims.
News
Generic versions of Suboxone approved for opioid dependence
The FDA says patients who receive medication-assisted treatment for opioid use disorder reduce their risk of death from all causes by 50%.
Conference Coverage
Mobile app engages individuals with opioid use disorders
Participants’ scores on the medication-assisted treatment attitudes scale rose from a mean of 3.3 to a mean of 3.5 (P = 0.044).
From the Journals
Most U.S. buprenorphine prescribers assess patients for diversion
More than 80% of prescribers are willing to terminate treatment because of diversion concerns, survey shows.